Journal of Clinical & Translational Endocrinology · 2018 · 64 citations · 36 references
MedicineEndocrinologyDiabetologyInflammationMetabolic PhysiologyAdipose TissueDiabetes MellitusDiabetes Mellitus BiochemistryInsulin ResistanceMetabolic EndocrinologyMetabolic SyndromeAdipose Tissue Insulin ResistanceBlood Glucose RegulationGlucose Homeostasis DisturbanceGlucose Metabolism BiomarkersInsulin Resistance AssessmentLipid Profile ChangesObesity-associated Insulin ResistanceWaist Circumference Measurement
BACKGROUND: Omentin-1 a new anti-inflammatory adipokine has been identified as a major visceral (omental) secretory adipokine which plays important roles in glucose homeostasis, lipid metabolism, insulin resistance and diabetes. The aim of our study was to evaluate serum omentin-1 levels in type 2 diabetic obese females and assess its relation with glycemic control, insulin resistance and metabolic parameters. METHODS: The study included 60 obese type 2 diabetic females and 30 healthy female subjects formed the control group. They subjected to full clinical examination, weight, height, waist and hip circumference. Fasting (blood glucose, insulin, lipid profile, omentin-1) and HbA1c were measured. BMI and HOMA-IR were calculated. Our data analyzed and expressed in terms of mean ± SD. Pearson correlation performed to study the correlation of serum omentin-1 in relation to glycemic control, insulin resistance and metabolic parameters in the studied groups. RESULTS: = 0.031). The best cut off point of serum omentin-1 was 22.2 pg/ml to differentiate cases from controls using ROC curve analysis. CONCLUSION: Our study has shown significant low levels of serum omentin-1 in obese type 2 diabetic females in comparison to healthy subjects. Omentin-1 inversely related to obesity, insulin resistance and SBP. No significant associations with glycemic control and fasting lipids. Serum omentin-1 can be used as a biomarker for obesity related metabolic disorders.
36
International Diabetes Federation 2017
Ann M. Carracher, Payal H. Marathe, Kelly L. Close · Journal of Diabetes · 2018 · 13.6K citations · Full text
Medicine, Endocrinology, Diabetology +11